Durham, NC, United States of America

Matthew G Jenks

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2008-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Matthew G. Jenks

Introduction

Matthew G. Jenks is a notable inventor based in Durham, NC, who has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, he has focused on developing novel compounds that can aid in the treatment of fertility disorders.

Latest Patents

Among his latest patents are benzamide derivatives that serve as positive allosteric modulators of the follicle-stimulating hormone (FSH) receptor. These novel benzamide derivatives, characterized by specific chemical formulas, have the potential to be employed in treating various fertility disorders. The innovative nature of these compounds highlights Jenks' commitment to advancing medical science.

Career Highlights

Throughout his career, Matthew G. Jenks has worked with prominent companies such as Merck Patent GmbH and Serenex, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Jenks has collaborated with esteemed colleagues, including Henry Yu and Thomas E. Richardson. These partnerships have fostered an environment of innovation and creativity, further enhancing the impact of his work.

Conclusion

Matthew G. Jenks exemplifies the spirit of innovation in the pharmaceutical field. His contributions, particularly in the development of benzamide derivatives, showcase his dedication to improving fertility treatments. His work continues to inspire future advancements in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…